Antibody Drug Conjugate (ADC) Cleaning Validation: Managing Complexity Across the Product Lifecycle

Antibody drug conjugate (ADC) products introduce unique cleaning validation challenges in biotechnology manufacturing. The integration of small and large molecule components increases overall cleaning validation complexity and directly impacts cleaning methods, analytical strategy selection and limit setting, particularly for high potency compounds and degradation pathways.

Join this complimentary webinar to learn key cleaning validation and contamination control considerations for ADC products. Discover best practices for cleaning individual components and the final conjugate. Gain practical guidance on grouping strategies, analytical method selection and the establishment of degradation and exposure based limits. Additionally, explore how insights from the design phase can inform qualification activities and ongoing monitoring across the cleaning validation lifecycle.